Setbone Medical
Novel Treatment for Vertebral Compression Fractures
Company Overview
Snapshot
Founded in December 2017 by Royi Kaufmann and Nimrod Kaufmann, Setbone Medical operates with 1–10 employees. The company has raised $1.6 million across two funding rounds from four investors, with The Trendlines Group participating as a lead investor. In January 2022, Setbone Medical announced a $1.6 million financing round.
Business overview
Setbone Medical is a Health Tech & Life Sciences company developing a novel bone cement for the treatment of vertebral compression fractures (VCF), primarily caused by osteoporosis. The company's proprietary acrylic bone cement is designed to overcome the limitations of current cements by not containing toxic monomers and offering a ready-to-use, prefilled cartridge. This dual-paste, mix-on injection system provides extended working time and a low exothermic reaction to prevent damage to surrounding tissue. Setbone Medical operates in the medical technologies and treatments sectors, serving global markets with its product currently in clinical trials.
Strategic signal
In January 2022, Setbone Medical announced a $1.6 million financing, signaling continued investor confidence in its novel bone cement technology. This funding is crucial for advancing the company's product, which is currently in clinical trials, and indicates a positive trajectory for its development and potential market entry in the orthopedic and biomaterials sectors.
Company Intelligence Q&A
- What is Setbone Medical's primary focus?
- Setbone Medical is focused on developing a novel bone cement for the treatment of vertebral compression fractures (VCF) caused by osteoporosis.
- When was Setbone Medical founded?
- Setbone Medical was founded in December 2017.
- Who are the founders of Setbone Medical?
- Setbone Medical was founded by Royi Kaufmann and Nimrod Kaufmann.
- What was a significant financing event for Setbone Medical?
- In January 2022, Setbone Medical announced a $1.6 million financing round with participation from.
- Which investor participated in Setbone Medical's funding rounds?
- The Trendlines Group participated as a lead investor in Setbone Medical's funding rounds, including the January 2022 financing and a round in December 2017.